FV Hospital aims to develop into a leading robotic surgery hub in Southeast Asia, with the long-term goal of making the world ...

The biopsy came back positive. It’s lung cancer.” Countless people in our community hear these words no one ever expects.

Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.

Shira Kupperman Boehler went on a 6-mile run the morning before doctors told her they suspected she had lung cancer. She didn’t believe them. The 44-year-old finance investment analyst and mom of four ...

Researchers at the University of Gothenburg have identified a protein linked to an increased risk of metastasis and recurrence in lung cancer. The findings are presented in a study published in the ...

With lung cancer the leading cause of cancer death both in the UK and globally, the UK's National Health Service (NHS) has launched a trial of AI lung scan analysis and robot-guided biopsies in an ...

Jan Lowery does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

Many eligible patients miss lung cancer screening due to low awareness and systemic barriers, putting underserved groups at higher risk for late-stage disease. She also explained the differences in ...

A protein already targeted by FDA-approved cancer drugs may also help the body fight influenza, according to new research from The Jackson Laboratory (JAX). Published in Cell Reports, the study found ...

This gap has persisted with minimal improvement since the early 1990s, researchers reported March 2 in JAMA Network Open. “The past 30 years have seen tremendous progress in our fundamental ...

The US Food and Drug Administration (FDA) has fast-tracked a promising new gene therapy, KB707, which is inhaled as a fine mist for the targeted treatment of advanced or metastatic non-small-cell lung ...